To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Inovio's handheld Cellectra device is essential to ...
Last week the United States Food and Drug Administration (FDA) authorized the biotechnology company Inovio to move forward with clinical trials in the United States to test their DNA-based plasmid ...
NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (INO) and certain officers. The class action, filed in ...
What are the allegations? Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. Misled Investors Regarding Approval for its CELLECTRA Device According to the complaint, during the ...
PLYMOUTH MEETING, Pa., June 23, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results